Johnson & Johnson’s Latest Recall, Kodiak’s Buy Pays Off, and 3 More Hot Stocks

  Google+  Twitter | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson (NYSE:JNJ): The pharmaceutical and health care giant is is recalling 5,000 vials of its Risperdal Consta schizophrenia treatment after tests found that one lot of the drug was contaminated with alternaria alternata, a common mold. The recall is preemptive, as no reports of patient complications have surfaced. Just last week, Johnson & Johnson recalled 200,000 bottles of its Motrin Infants Drops formula due to a risk that they contained tiny plastic particles.

JNJ 20130912

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business